BlackRock Fund Advisors’s Xtant Medical Holdings XTNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1K Buy
121
+19
+19% +$164 ﹤0.01% 4205
2016
Q3
$1K Buy
102
+12
+13% +$221 ﹤0.01% 4232
2016
Q2
$2K Buy
+90
New +$2.32K ﹤0.01% 4231

Other funds holding XTNT

BlackRock Fund Advisors's XTNT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Xtant Medical Holdings (XTNT) stake by 19% in Q4 2016, buying an estimated $164 and bringing the position to 121 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #4205.

BlackRock Fund Advisors first reported a position in XTNT in Q2 2016 and has held it in 3 quarters since. The position peaked at $2K in Q2 2016. 22 funds tracked by Wall St. Rank hold XTNT as of Q4 2016.

  • BlackRock Fund Advisors held 121 shares of Xtant Medical Holdings worth $1K as of Q4 2016.
  • BlackRock Fund Advisors bought 19 Xtant Medical Holdings shares in Q4 2016, an estimated $164.
  • Xtant Medical Holdings made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4205 holding.
  • BlackRock Fund Advisors first reported a position in Xtant Medical Holdings in Q2 2016 and has held it in 3 quarters since.
  • BlackRock Fund Advisors's Xtant Medical Holdings position peaked at $2K in Q2 2016.
  • 22 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.